ArticleNeuro-oncology advances

Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib.

Yoshiki Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.